Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-319
Pteroic Acid
Cat. No.
AKA-319
CAS No.
119-24-4
MF
C14H12N6O3
MW
312.28
Pteroic acid is a precursor to significant compounds like Folic acid and Vitamin B12.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Pteroic Acid
CAS No.
119-24-4
MF
C14H12N6O3
MW
312.28
Specification
95%
Research Area
Pteroic acid serves as the core structural component of folic acid, primarily utilized as a pharmaceutical intermediate for synthesizing folic acid derivatives and researching antagonists of specific toxins.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Description
Pteroic acid is a precursor to significant compounds like Folic acid and Vitamin B12. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store sealed, protected from light, at 2-8°C.
References
[1]. Vickers PJ, et al. Activation of folypolyglutamate synthetase by pteroic acid. Canadian Journal of Biochemistry and Cell Biology = Revue Canadienne De Biochimie Et Biologie Cellulaire. 1985 Jul;63(7):777-9.
[2]. Ke CY, et al. Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid. Journal of the American Chemical Society. 2005;127(20):7421-7426.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
